Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 96

Sort by

Sort Order Select

Journal Articles

Survival of Hemodialysis-Dependent Multiple Myeloma Patients and Factors Associated with Dialysis Independence: A Real-World Study in China

Chenyun Wang, Jinuo Wang, Yang Yang, Donghua He, Gaofeng Zheng, Xiaoyan Han, Jingsong He, Jinping Ying, Wenjun Wu, Zhen Cai

Blood (2024) 144 (Supplement 1): 6913.

https://doi.org/10.1182/blood-2024-201472

Published: 2024

Journal Articles

Study on the Molecular Genetic Characteristics of Multiple Myeloma Patients in China

Yang Yang, Jingsong He, Gaofeng Zheng, Xiaoyan Han, Yang Nie, Li Sun, Haoran Ma, Ying Wu, Jie Zhang, Zhen Cai

Blood (2024) 144 (Supplement 1): 6816.

https://doi.org/10.1182/blood-2024-202862

Published: 2024

Journal Articles

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Qingxiao Chen, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Jing Chen, Xiaoyan Han, Li Yang, Wenjun Wu, YI LI, Donghua He, Jingsong He, Zhen Cai

Blood (2024) 144 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2024-197887

Published: 2024

Journal Articles

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Yang Yang, Wenjing Wang, Liang Ren, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Jing Li, Jiadai Xu, Tianhong Xu, Fei-fei Chen, Peng Liu

Blood (2024) 144 (Supplement 1): 6956.

https://doi.org/10.1182/blood-2024-207788

Published: 2024

Journal Articles

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Mengmeng Dong, Xiao Xiao, Zhen Cai, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Li Yang, Haimeng Yan

Blood (2024) 144 (Supplement 1): 6894.

https://doi.org/10.1182/blood-2024-210534

Published: 2024

Journal Articles

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Jing Li, Yang Yang, Chenqi Yu, Yuxia Yang, Peng Liu

Blood (2024) 144 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2024-207188

Published: 2024

Journal Articles

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Blood (2024) 144 (Supplement 1): 5092.

https://doi.org/10.1182/blood-2024-198455

Published: 2024

Journal Articles

Aging-disturbed FUS phase transition impairs hematopoietic stem cells by altering chromatin structure

Baixue Tang, Xinming Wang, Hanqing He, Ruiqing Chen, Guofeng Qiao, Yang Yang, Zihan Xu, Longteng Wang, Qiongye Dong, Jia Yu, Michael Q. Zhang, Minglei Shi, Jianwei Wang

Blood (2024) 143 (2): 124–138.

https://doi.org/10.1182/blood.2023020539

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

The Efficacy of Roxadustat in Multiple Myeloma Patients with Renal Insufficiency and Anemia: A Real-World Study

Shuchan Li, Xiaoyan Han, Gaofeng Zheng, Jingsong He, Wenjun Wu, Yang Yang, Qingxiao Chen, Donghua He, Mengmeng Dong, Jinuo Wang, Yi Li, Li Yang, Zhen Cai

Blood (2023) 142 (Supplement 1): 4726.

https://doi.org/10.1182/blood-2023-184617

Published: 2023

Journal Articles

MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study

Yang Cao, Wenxuan Huo, Yang Yang, Jiayu Huang, Yu Wang, Liang Huang, Yingjun Chang, Xiaoxia Hu, Xiaodong Mo

Blood (2023) 142 (Supplement 1): 3620.

https://doi.org/10.1182/blood-2023-185667

Published: 2023

Journal Articles

Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience

Yang Yang, Adam F. Binder, Xia Bi, Joanne Filicko-O'Hara, William O'Hara, Neal Flomenberg, Dolores A. Grosso, John L. Wagner, Arpona Dev Nath, Sikemi Ibikunle, Eliabeth Spitz, Usama Gergis

Blood (2023) 142 (Supplement 1): 7110.

https://doi.org/10.1182/blood-2023-173576

Published: 2023

Journal Articles

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Linlin Huang, Hanjin Yang, Yang Yang, Fang Yu, Yi Zhao, Xiujin Ye, Weiyan Zheng, Jie Sun, Enfan Zhang, Zhen Cai, Jingsong He

Blood (2023) 142 (Supplement 1): 4448.

https://doi.org/10.1182/blood-2023-186056

Published: 2023

Journal Articles

Avatrombopag Is Effective in First-Line Treatment of Severe Aplastic Anemia: Early Outcomes of a Prospective Study

Xin Zhao, Jianping Li, Huihui Fan, Liping Jing, Li Zhang, Kang Zhou, Wenrui Yang, Yuan Li, Yang Yang, Lei Ye, Guangxin Peng, Youzhen Xiong, Jun Shi, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 4087.

https://doi.org/10.1182/blood-2023-190948

Published: 2023

Journal Articles

Exclusive Benefits of Sustained MRD-Negative in High-Risk Multiple Myeloma

Liang Ren, Tianhong Xu, Wenjing Wang, Yang Yang, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Panpan Li, Chi Zhou, Pu Wang, Peng Liu

Blood (2023) 142 (Supplement 1): 6663.

https://doi.org/10.1182/blood-2023-172450

Published: 2023

Journal Articles

Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective Cohort Study

Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Wenjun Wu, Yi Zhao, Yi Li, Zhen Cai

Blood (2023) 142 (Supplement 1): 6639.

https://doi.org/10.1182/blood-2023-184794

Published: 2023

Journal Articles

Clinical Characteristics Analysis of Gastrointestinal Peripheral T-Cell Lymphoma:Impact of Non-Emergency Surgery on Overall Survival

Jingsong He, Linlin Huang, Yang Yang, Yi Zhao, Xiu-Jin Ye, Weiyan Zheng, Sun Jie, Zhen Cai

Blood (2023) 142 (Supplement 1): 6214.

https://doi.org/10.1182/blood-2023-185509

Published: 2023

Journal Articles

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Tianhong Xu, Jing Li, Yang Yang, Wenjing Wang, Pu Wang, Chenqi Yu, Peng Liu

Blood (2023) 142 (Supplement 1): 6770.

https://doi.org/10.1182/blood-2023-184754

Published: 2023

Journal Articles

Clinical Characterization of Hepatic Light Chain Amyloidosis in the Chinese Population: A Single-Center Retrospective Analysis

Chen Chen, Chenqi Yu, Jing Li, Weiguang Wang, Zhimei Wang, Lu-Ya Cheng, Fei-fei Chen, Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Pu Wang, Peng Liu

Blood (2023) 142 (Supplement 1): 6745.

https://doi.org/10.1182/blood-2023-186600

Published: 2023

Journal Articles

Preliminary Outcomes of Orelabrutinib Plus R-CHOP in Treatment-Naive Patients with Double-Expression Diffuse Large B-Cell Lymphoma

Yang Yang, Jingsong He, Yi Zhao, Wenjun Wu, Gaofeng Zheng, Xiaoyan Han, Donghua He, Tao Cheng, Zhen Cai

Blood (2023) 142 (Supplement 1): 6222.

https://doi.org/10.1182/blood-2023-187906

Published: 2023

Journal Articles

A Comparative Study of Clinical Characteristics, Cytogenetic Abnormalities and Outcomes Among Multiple Myeloma, Primary Light-Chain Amyloidosis and Multiple Myeloma with Concurrent AL Amyloidosis

Chenqi Yu, Jing Li, Tianhong Xu, Wenjing Wang, Pu Wang, Yang Yang, Peng Liu

Blood (2023) 142 (Supplement 1): 2032.

https://doi.org/10.1182/blood-2023-188350

Published: 2023

NARROW

Survival of Hemodialysis-Dependent Multiple Myeloma Patients and Factors Associated with Dialysis Independence: A Real-World Study in China

Study on the Molecular Genetic Characteristics of Multiple Myeloma Patients in China

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Aging-disturbed FUS phase transition impairs hematopoietic stem cells by altering chromatin structure

The Efficacy of Roxadustat in Multiple Myeloma Patients with Renal Insufficiency and Anemia: A Real-World Study

MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study

Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Avatrombopag Is Effective in First-Line Treatment of Severe Aplastic Anemia: Early Outcomes of a Prospective Study

Exclusive Benefits of Sustained MRD-Negative in High-Risk Multiple Myeloma

Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective Cohort Study

Clinical Characteristics Analysis of Gastrointestinal Peripheral T-Cell Lymphoma:Impact of Non-Emergency Surgery on Overall Survival

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Clinical Characterization of Hepatic Light Chain Amyloidosis in the Chinese Population: A Single-Center Retrospective Analysis

Preliminary Outcomes of Orelabrutinib Plus R-CHOP in Treatment-Naive Patients with Double-Expression Diffuse Large B-Cell Lymphoma

A Comparative Study of Clinical Characteristics, Cytogenetic Abnormalities and Outcomes Among Multiple Myeloma, Primary Light-Chain Amyloidosis and Multiple Myeloma with Concurrent AL Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only